Overview
A Study to Investigate the Efficacy, Safety of CT-P27 in Acute Uncomplicated Influenza A Infection
Status:
Unknown status
Unknown status
Trial end date:
2018-07-31
2018-07-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
to evaluate the Efficacy and Safety of CT-P27 comparing placeboPhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Celltrion
Criteria
Inclusion Criteria:- Male or Female subjects between the ages of 19 and 65 years, both inclusive
- Diagnosed with influenza A at screening.
- ≥38'C body temperature at screening
Exclusion Criteria:
- Taking antiviral treatment for influenza or has a history of using these antivirals
within 14 days prior to the administration of study drug.
- Positive influenza B or A+B infection